The content discusses the development of a long-lasting GLP-1 injection that could potentially last for 4 months, revolutionizing diabetes treatment. The injectable hydrogel depot developed by Stanford engineers gradually releases GLP-1, offering a promising solution for diabetes management. The article highlights the importance of patient adherence and the potential impact of this innovative drug delivery system on diabetes care. It also mentions the advancements in long-acting injectables for various medical conditions and the unique characteristics of the hydrogel developed by Appel's team at Stanford.
To Another Language
from source content
www.medscape.com
Key Insights Distilled From
by Clarissa at www.medscape.com 12-14-2023
https://www.medscape.com/viewarticle/what-if-single-glp-1-shot-could-last-months-2023a1000vdnDeeper Inquiries